BR112019023817A8 - Composições tópicas e métodos para o tratamento de doenças da pele - Google Patents
Composições tópicas e métodos para o tratamento de doenças da peleInfo
- Publication number
- BR112019023817A8 BR112019023817A8 BR112019023817A BR112019023817A BR112019023817A8 BR 112019023817 A8 BR112019023817 A8 BR 112019023817A8 BR 112019023817 A BR112019023817 A BR 112019023817A BR 112019023817 A BR112019023817 A BR 112019023817A BR 112019023817 A8 BR112019023817 A8 BR 112019023817A8
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- treatment
- skin diseases
- topical compositions
- treating
- Prior art date
Links
- 208000017520 skin disease Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 abstract 1
- 239000007764 o/w emulsion Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960000565 tazarotene Drugs 0.000 abstract 1
- IQIBKLWBVJPOQO-UHFFFAOYSA-N tazarotenic acid Chemical compound C1=C2C(C)(C)CCSC2=CC=C1C#CC1=CC=C(C(O)=O)C=N1 IQIBKLWBVJPOQO-UHFFFAOYSA-N 0.000 abstract 1
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762505421P | 2017-05-12 | 2017-05-12 | |
| US62/505,421 | 2017-05-12 | ||
| PCT/US2018/032359 WO2018209262A1 (en) | 2017-05-12 | 2018-05-11 | Topical compositions and methods for treating skin diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112019023817A2 BR112019023817A2 (pt) | 2020-06-02 |
| BR112019023817A8 true BR112019023817A8 (pt) | 2022-12-06 |
Family
ID=62386996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019023817A BR112019023817A8 (pt) | 2017-05-12 | 2018-05-11 | Composições tópicas e métodos para o tratamento de doenças da pele |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20180360752A1 (https=) |
| EP (1) | EP3621614B1 (https=) |
| JP (1) | JP7410720B2 (https=) |
| BR (1) | BR112019023817A8 (https=) |
| CA (1) | CA3063371A1 (https=) |
| PL (1) | PL3621614T3 (https=) |
| RS (1) | RS67211B1 (https=) |
| WO (1) | WO2018209262A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6997624B2 (ja) | 2015-06-18 | 2022-01-17 | ボシュ ヘルス ユーエス，エルエルシー． | 乾癬を治療するためのコルチコステロイドおよびレチノイドを含む局所用組成物 |
| US11311482B2 (en) | 2017-05-12 | 2022-04-26 | Bausch Health Us, Llc | Topical compositions and methods for treating skin diseases |
| US20260007646A1 (en) * | 2022-09-16 | 2026-01-08 | Bausch Health Ireland Limited | Methods for treating acne and skin oiliness with tazarotene |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1210041C (zh) * | 2003-09-29 | 2005-07-13 | 中国医学科学院皮肤病研究所 | 治疗痤疮的复方外用药物 |
| JP6997624B2 (ja) | 2015-06-18 | 2022-01-17 | ボシュ ヘルス ユーエス，エルエルシー． | 乾癬を治療するためのコルチコステロイドおよびレチノイドを含む局所用組成物 |
-
2018
- 2018-05-11 JP JP2019562657A patent/JP7410720B2/ja active Active
- 2018-05-11 EP EP18727965.8A patent/EP3621614B1/en active Active
- 2018-05-11 US US15/977,088 patent/US20180360752A1/en not_active Abandoned
- 2018-05-11 WO PCT/US2018/032359 patent/WO2018209262A1/en not_active Ceased
- 2018-05-11 BR BR112019023817A patent/BR112019023817A8/pt not_active Application Discontinuation
- 2018-05-11 CA CA3063371A patent/CA3063371A1/en active Pending
- 2018-05-11 PL PL18727965.8T patent/PL3621614T3/pl unknown
- 2018-05-11 RS RS20250918A patent/RS67211B1/sr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020519656A (ja) | 2020-07-02 |
| PL3621614T3 (pl) | 2025-10-13 |
| US20180360752A1 (en) | 2018-12-20 |
| RS67211B1 (sr) | 2025-10-31 |
| EP3621614B1 (en) | 2025-06-25 |
| EP3621614A1 (en) | 2020-03-18 |
| CA3063371A1 (en) | 2018-11-15 |
| BR112019023817A2 (pt) | 2020-06-02 |
| WO2018209262A1 (en) | 2018-11-15 |
| JP7410720B2 (ja) | 2024-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019002730A2 (pt) | acetil-leucina, ou um sal farmaceuticamente aceitável da mesma, para uso em um método de tratamento de uma doença neurodegenetativa | |
| CL2019000979A1 (es) | Composiciones y anticuerpos anti-lag-3. | |
| WO2018022668A3 (en) | NEUROMODULATORY COMPOSITIONS AND ASSOCIATED METHODS OF TREATING CANCER | |
| CL2018001897A1 (es) | Composiciones para modular la expresión de sod-1 (divisional solicitud 201602509) | |
| BR112017014341A2 (pt) | método e sistema para tratamento, estabilização, ou redução da gravidade ou progressão de uma doença de fígado gorduroso não alcoólica, e, composição. | |
| MX2016000364A (es) | Metodos para tratar o prevenir afecciones oftalmologicas. | |
| BR112016029334A2 (pt) | produto farmacêutico, uso de um anticorpo, kit, método para tratar um paciente com câncer e métodos e usos de novos produtos | |
| MX2017015938A (es) | Inhibidores de ezh2 para el tratar linfomas. | |
| EA201890725A1 (ru) | Агонисты фарнезоидного х-рецептора и их применение | |
| WO2015117010A3 (en) | Bag3 as a target for therapy of heart failure | |
| BR112017003571A2 (pt) | terapia combinada | |
| BR112016027043A8 (pt) | combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer | |
| BR112018005905A2 (pt) | ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto? | |
| BR112017009552A8 (pt) | Métodos para alvejar o controle transcricional em regiões de super-realçador | |
| BR112017018964A2 (pt) | uso de plinabulin e métodos para tratar tumor cerebral | |
| BR112018001435A2 (pt) | métodos para entrega linfática de agentes ativos | |
| EA201991374A1 (ru) | Водорастворимое производное эпиаллопрегнанолона и его применение | |
| MX392470B (es) | Composición farmacéutica que comprende un péptido wt1 para el tratamiento o prevención de una enfermedad angiogénica. | |
| MX2021010041A (es) | Composiciones farmaceuticas que comprenden inhibidores de la proteina quinasa akt. | |
| BR112017014793A2 (pt) | regime de dosagem para antagonistas de madcam | |
| EA201892265A1 (ru) | Способы лечения офтальмологических заболеваний | |
| BR112018014762A2 (pt) | método de tratamento da doença de alzheimer (da) precoce | |
| MX380290B (es) | Composiciones y métodos para el tratamiento y la prevención de trastornos neurodegenerativos. | |
| BR112019023817A8 (pt) | Composições tópicas e métodos para o tratamento de doenças da pele | |
| PH12020551179A1 (en) | Methods for treating mitochondrial disorder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: BAUSCH HEALTH IRELAND LIMITED (IE) |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |